Skip to content
  • About Us
  • Investment Focus
  • Team
  • Portfolio
  • News
  • Contact Us
Kamada Announces Positive Interim Results from Phase I/II Clinical Study of its human Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease

http://www.kamada.com/news_item.php?ID=129